Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
| Form | Size | Price | $/mg | Stock | Updated |
|---|---|---|---|---|---|
| vial | 40mg | $79.99 | $2.00/mg | In stock | Jul 27 |
Single-vial list prices — bulk or bundle orders may be lower. Verify at vendor before purchase.
| Lot / Report | Tested | Purity | Lab | Panels | Status | |
|---|---|---|---|---|---|---|
| RR-MS-2607 | Jul 2026 | 99.5% | Freedom Diagnostics | Endotoxin | Confirmed | View |
Removed from Category 2 on April 22, 2026; in no FDA category today. On the July 23–24, 2026 PCAC advisory docket for obesity and osteoporosis — not authorized for compounding. The FDA removed 12 substances from Category 2 effective April 22, 2026 because the nominations were withdrawn by the nominators, not because the FDA cleared anything — removal does not place a substance in Category 1 or on the 503A bulks list, so these compounds now sit in no FDA category at all. The Pharmacy Compounding Advisory Committee is advisory only — it met July 23–24, 2026 (docket FDA-2025-N-6895) to review nominations and make recommendations, and the FDA issues any final rule later, typically 6–18 months afterward. Listing decisions are specific to the proposed use.
Does Rescue Research USA sell MOTS-c?
Yes — Rescue Research USA currently lists MOTS-c in 1 variant starting at $79.99 ($2.00/mg).
Is Rescue Research USA's MOTS-c third-party tested?
Yes — Disclosed Labs has indexed 3 Certificates of Analysis for Rescue Research USA's MOTS-c, with the most recent showing 99.5% purity. Rescue Research USA holds an overall trust grade of C (73/100) across all 31 COAs on file.
What is Rescue Research USA's trust grade for MOTS-c?
Rescue Research USA has an overall Disclosed Labs trust grade of C (73/100), computed from 31 COAs across all peptides. The most recent MOTS-c COA was issued by Freedom Diagnostics.
Where is the cheapest MOTS-c?
As of the latest data, Peptide Supply Co. offers MOTS-c at $1.25/mg — compare with Rescue Research USA's listing at $2.00/mg. See the full MOTS-c price comparison.
What is the FDA compounding status of MOTS-c?
Removed from Category 2 on April 22, 2026; in no FDA category today. On the July 23–24, 2026 PCAC advisory docket for obesity and osteoporosis — not authorized for compounding. The FDA removed 12 substances from Category 2 effective April 22, 2026 because the nominations were withdrawn by the nominators, not because the FDA cleared anything — removal does not place a substance in Category 1 or on the 503A bulks list, so these compounds now sit in no FDA category at all. The Pharmacy Compounding Advisory Committee is advisory only — it met July 23–24, 2026 (docket FDA-2025-N-6895) to review nominations and make recommendations, and the FDA issues any final rule later, typically 6–18 months afterward. Listing decisions are specific to the proposed use. Sales tracked here are for research purposes only. Disclosed Labs does not provide medical or legal advice.
| WP-MS-2606 | Jun 2026 | 99.6% | Freedom Diagnostics | Endotoxin | Confirmed | View |
| Black Cap | Apr 2026 | 99.4% | Freedom Diagnostics | — | Unverified | View |
Disclosed Labs